文献速递细菌感染、耐药与抗菌药物医院感染防控

美国928家医院经验性革兰阴性菌抗生素使用的模式、预测因素及院际差异

Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals.
PubMed 文献 · Clin Infect Dis · 2023-01-01

基于2019年Premier数据库928家医院8017740例住院成人的回顾性队列研究,2928657例(37%)接受经验性革兰阴性菌抗生素,其中1781306例接受广谱治疗者中30%无常见感染综合征、手术或ICU停留;男性接受广谱治疗的可能性高22%,非白人种族低6%-13%,校正后院际差异可达34个百分点以上。

要点

  • 37%住院成人接受经验性革兰阴性菌抗生素,广谱治疗者中30%无常见感染综合征、手术或ICU停留。
  • 男性接受广谱治疗的可能性高22%(aOR 1.22,95%CI 1.22-1.23),非白人种族低6%-13%(aOR 0.87-0.94)。
  • 校正后仅因收治医院不同,广谱抗生素使用概率差异可达34个百分点以上(95%区间43%-77%)。

核心结论

  • 经验性革兰阴性菌抗生素使用在美国各地区间高度变异,且存在高度无法解释的院际差异。
  • 性别和种族在接受广谱治疗上的差异需进一步研究。

研究设计与样本

  • 回顾性队列研究,纳入2019年从美国Premier Healthcare Database中928家医院出院的成人。
  • 经验性革兰阴性菌抗生素定义为住院第3天前给药。
  • 采用按医院随机效应的多变量逻辑回归模型,评估患者和医院特征与接受广谱(对比窄谱)革兰阴性菌抗生素的关联。

主要发现

  • 8017740例住院成人中,2928657例(37%)接受经验性革兰阴性菌抗生素。
  • 1781306例接受广谱治疗者中,30%在入院时无常见感染综合征(肺炎、尿路感染、脓毒症或菌血症)、手术或经验性窗口期ICU停留。
  • 校正其他因素后,男性接受广谱治疗的可能性高22%(aOR 1.22,95%CI 1.22-1.23),所有非白人种族低6%-13%(aOR范围0.87-0.94)。
  • 各地区处方存在显著差异,美国West South Central分区广谱治疗的校正比值比最高。
  • 即使模型校正后,院际差异仍显著:接受经验性治疗的患者中,仅因收治医院不同,接受广谱抗生素的概率差异可达34个百分点以上(95%概率区间43%-77%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 性别和种族在接受广谱治疗上的差异需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Empiric antibiotic use among hospitalized adults in the United States (US) is largely undescribed. Identifying factors associated with broad-spectrum empiric therapy may inform antibiotic stewardship interventions and facilitate benchmarking. METHODS: We performed a retrospective cohort study of adults discharged in 2019 from 928 hospitals in the Premier Healthcare Database. "Empiric" gram-negative antibiotics were defined by administration before day 3 of hospitalization. Multivariable logistic regression models with random effects by hospital were used to evaluate associations between patient and hospital characteristics and empiric receipt of broad-spectrum, compared to narrow-spectrum, gram-negative antibiotics. RESULTS: Of 8 017 740 hospitalized adults, 2 928 657 (37%) received empiric gram-negative antibiotics. Among 1 781 306 who received broad-spectrum therapy, 30% did not have a common infectious syndrome present on admission (pneumonia, urinary tract infection, sepsis, or bacteremia), surgery, or an intensive care unit stay in the empiric window. Holding other factors constant, males were 22% more likely (adjusted odds ratio [aOR], 1.22 [95% confidence interval, 1.22-1.23]), and all non-White racial groups 6%-13% less likely (aOR range, 0.87-0.94), to receive broad-spectrum therapy. There were significant prescribing differences by region, with the highest adjusted odds of broad-spectrum therapy in the US West South Central division. Even after model adjustment, there remained substantial interhospital variability: Among patients receiving empiric therapy, the probability of receiving broad-spectrum antibiotics varied as much as 34+ percentage points due solely to the admitting hospital (95% interval of probabilities: 43%-77%). CONCLUSIONS: Empiric gram-negative antibiotic use is highly variable across US regions, and there is high, unexplained interhospital variability. Sex and racial disparities in the receipt of broad-spectrum therapy warrant further investigation.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Goodman KE, Baghdadi JD, Magder LS, et al. Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals. Clin Infect Dis. 2023. PMID: 35737945. doi:10.1093/cid/ciac504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。